These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33640432)

  • 21. An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo.
    Lymperopoulos A; Rengo G; Zincarelli C; Kim J; Soltys S; Koch WJ
    Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5825-30. PubMed ID: 19289825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-arrestins in the context of cardiovascular diseases: Focusing on angiotensin II type 1 receptor (AT1R).
    Lino CA; Barreto-Chaves ML
    Cell Signal; 2022 Apr; 92():110253. PubMed ID: 35077849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationship study of angiotensin II analogs in terms of β-arrestin-dependent signaling to aldosterone production.
    Valero TR; Sturchler E; Jafferjee M; Rengo G; Magafa V; Cordopatis P; McDonald P; Koch WJ; Lymperopoulos A
    Pharmacol Res Perspect; 2016 Apr; 4(2):e00226. PubMed ID: 27069636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Label-free cell signaling pathway deconvolution of angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIIIIV responses.
    Lavenus S; Simard É; Besserer-Offroy É; Froehlich U; Leduc R; Grandbois M
    Pharmacol Res; 2018 Oct; 136():108-120. PubMed ID: 29959993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The place of ARBs in heart failure therapy: is aldosterone suppression the key?
    Markan U; Pasupuleti S; Pollard CM; Perez A; Aukszi B; Lymperopoulos A
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719868134. PubMed ID: 31401939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 receptor.
    Nivedha AK; Lee S; Vaidehi N
    J Mol Graph Model; 2023 Jan; 118():108365. PubMed ID: 36335829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping Angiotensin II Type 1 Receptor-Biased Signaling Using Proximity Labeling and Proteomics Identifies Diverse Actions of Biased Agonists.
    Pfeiffer CT; Wang J; Paulo JA; Jiang X; Gygi SP; Rockman HA
    J Proteome Res; 2021 Jun; 20(6):3256-3267. PubMed ID: 33950683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.
    Bonde MM; Hansen JT; Sanni SJ; Haunsø S; Gammeltoft S; Lyngsø C; Hansen JL
    PLoS One; 2010 Nov; 5(11):e14135. PubMed ID: 21152433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways.
    Pang HW; Linares A; Couling L; Santollo J; Ancheta L; Daniels D; Speth RC
    Endocrine; 2019 Nov; 66(2):349-359. PubMed ID: 31020463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenal βarrestin1 targeting for tobacco-associated cardiac dysfunction treatment: Aldosterone production as the mechanistic link.
    Solesio ME; Mitaishvili E; Lymperopoulos A
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00497. PubMed ID: 31236278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor.
    Takezako T; Unal H; Karnik SS; Node K
    Mol Pharmacol; 2015 Sep; 88(3):488-501. PubMed ID: 26121982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
    Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
    J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor.
    Yatabe J; Yoneda M; Yatabe MS; Watanabe T; Felder RA; Jose PA; Sanada H
    Endocrinology; 2011 Apr; 152(4):1582-8. PubMed ID: 21303953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.
    Tadevosyan A; Maguy A; Villeneuve LR; Babin J; Bonnefoy A; Allen BG; Nattel S
    J Biol Chem; 2010 Jul; 285(29):22338-49. PubMed ID: 20463030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unraveling allostery within the angiotensin II type 1 receptor for Gα
    Cao Y; van der Velden WJC; Namkung Y; Nivedha AK; Cho A; Sedki D; Holleran B; Lee N; Leduc R; Muk S; Le K; Bhattacharya S; Vaidehi N; Laporte SA
    Sci Signal; 2023 Aug; 16(797):eadf2173. PubMed ID: 37552769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-molecule force spectroscopy study of interactions between angiotensin II type 1 receptor and different biased ligands in living cells.
    Li W; Xu J; Kou X; Zhao R; Zhou W; Fang X
    Anal Bioanal Chem; 2018 May; 410(14):3275-3284. PubMed ID: 29492619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional relevance of biased signaling at the angiotensin II type 1 receptor.
    Tilley DG
    Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):99-111. PubMed ID: 21476968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ezrin, radixin, and moesin phosphorylation in NIH3T3 cells revealed angiotensin II type 1 receptor cell-type-dependent biased signaling.
    Ibrahim IA; Nakaya M; Kurose H
    J Pharmacol Sci; 2013; 122(1):1-9. PubMed ID: 23575451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.
    Wingler LM; Skiba MA; McMahon C; Staus DP; Kleinhenz ALW; Suomivuori CM; Latorraca NR; Dror RO; Lefkowitz RJ; Kruse AC
    Science; 2020 Feb; 367(6480):888-892. PubMed ID: 32079768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.